https://stock.noler.com/us/stock/regenocell-therapeutics-inc https://stock.noler.com/us/stock/regenocell-therapeutics-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/regenocell-therapeutics-inc/accounts-receivable https://stock.noler.com/us/stock/regenocell-therapeutics-inc/accrued-salaries-current https://stock.noler.com/us/stock/regenocell-therapeutics-inc/accumulated-oci-foreign-currency-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/regenocell-therapeutics-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/regenocell-therapeutics-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/regenocell-therapeutics-inc/amended-reports-10-k https://stock.noler.com/us/stock/regenocell-therapeutics-inc/amended-reports-10-q https://stock.noler.com/us/stock/regenocell-therapeutics-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/regenocell-therapeutics-inc/asset-impairment-charges https://stock.noler.com/us/stock/regenocell-therapeutics-inc/business-development https://stock.noler.com/us/stock/regenocell-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/regenocell-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/regenocell-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/regenocell-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/regenocell-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/regenocell-therapeutics-inc/comprehensive-income https://stock.noler.com/us/stock/regenocell-therapeutics-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/regenocell-therapeutics-inc/convertible-notes-payable-current https://stock.noler.com/us/stock/regenocell-therapeutics-inc/cost-of-revenue https://stock.noler.com/us/stock/regenocell-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/regenocell-therapeutics-inc/current-assets https://stock.noler.com/us/stock/regenocell-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/regenocell-therapeutics-inc/deposits-assets-current https://stock.noler.com/us/stock/regenocell-therapeutics-inc/depreciation https://stock.noler.com/us/stock/regenocell-therapeutics-inc/depreciation-nonproduction https://stock.noler.com/us/stock/regenocell-therapeutics-inc/derivative-liabilities-current https://stock.noler.com/us/stock/regenocell-therapeutics-inc/due-to-related-parties-current https://stock.noler.com/us/stock/regenocell-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/regenocell-therapeutics-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/regenocell-therapeutics-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/regenocell-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/regenocell-therapeutics-inc/gain-loss-on-derivative-instruments-net-pretax https://stock.noler.com/us/stock/regenocell-therapeutics-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/regenocell-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/regenocell-therapeutics-inc/income-tax https://stock.noler.com/us/stock/regenocell-therapeutics-inc/income-taxes-paid https://stock.noler.com/us/stock/regenocell-therapeutics-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/regenocell-therapeutics-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/regenocell-therapeutics-inc/increase-decrease-in-customer-deposits https://stock.noler.com/us/stock/regenocell-therapeutics-inc/increase-decrease-in-derivative-liabilities https://stock.noler.com/us/stock/regenocell-therapeutics-inc/increase-decrease-in-employee-related-liabilities https://stock.noler.com/us/stock/regenocell-therapeutics-inc/increase-decrease-in-other-current-assets https://stock.noler.com/us/stock/regenocell-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/regenocell-therapeutics-inc/interest-expense https://stock.noler.com/us/stock/regenocell-therapeutics-inc/interest-paid https://stock.noler.com/us/stock/regenocell-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/regenocell-therapeutics-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/regenocell-therapeutics-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/regenocell-therapeutics-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/regenocell-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/regenocell-therapeutics-inc/net-income https://stock.noler.com/us/stock/regenocell-therapeutics-inc/notes-payable-current https://stock.noler.com/us/stock/regenocell-therapeutics-inc/notes-payable-related-parties-noncurrent https://stock.noler.com/us/stock/regenocell-therapeutics-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/regenocell-therapeutics-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-change https://stock.noler.com/us/stock/regenocell-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/regenocell-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/regenocell-therapeutics-inc/operating-income https://stock.noler.com/us/stock/regenocell-therapeutics-inc/other-current-assets https://stock.noler.com/us/stock/regenocell-therapeutics-inc/other-income https://stock.noler.com/us/stock/regenocell-therapeutics-inc/other-income-2 https://stock.noler.com/us/stock/regenocell-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/regenocell-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/regenocell-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/regenocell-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/regenocell-therapeutics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/regenocell-therapeutics-inc/preferred-stock-value https://stock.noler.com/us/stock/regenocell-therapeutics-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/regenocell-therapeutics-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/regenocell-therapeutics-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/regenocell-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/regenocell-therapeutics-inc/professional-fees https://stock.noler.com/us/stock/regenocell-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/regenocell-therapeutics-inc/public-float https://stock.noler.com/us/stock/regenocell-therapeutics-inc/related-party-transaction-expenses-from-transactions-with-related-party https://stock.noler.com/us/stock/regenocell-therapeutics-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/regenocell-therapeutics-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/regenocell-therapeutics-inc/restructuring-costs-and-asset-impairment-charges https://stock.noler.com/us/stock/regenocell-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/regenocell-therapeutics-inc/revenue https://stock.noler.com/us/stock/regenocell-therapeutics-inc/salaries-and-wages https://stock.noler.com/us/stock/regenocell-therapeutics-inc/salaries-wages-and-officers-compensation https://stock.noler.com/us/stock/regenocell-therapeutics-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/regenocell-therapeutics-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/regenocell-therapeutics-inc/sec-filings-10-k https://stock.noler.com/us/stock/regenocell-therapeutics-inc/sec-filings-10-q https://stock.noler.com/us/stock/regenocell-therapeutics-inc/sec-filings-10ksb https://stock.noler.com/us/stock/regenocell-therapeutics-inc/sec-filings-10qsb https://stock.noler.com/us/stock/regenocell-therapeutics-inc/sec-filings-10sb12g https://stock.noler.com/us/stock/regenocell-therapeutics-inc/sec-filings-8-k https://stock.noler.com/us/stock/regenocell-therapeutics-inc/sec-filings-regdex https://stock.noler.com/us/stock/regenocell-therapeutics-inc/sec-filings-revoked https://stock.noler.com/us/stock/regenocell-therapeutics-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/regenocell-therapeutics-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/regenocell-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/regenocell-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/regenocell-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/regenocell-therapeutics-inc/shares-outstanding-2 https://stock.noler.com/us/stock/regenocell-therapeutics-inc/total-assets https://stock.noler.com/us/stock/regenocell-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/regenocell-therapeutics-inc/total-liabilities-and-equity